PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 104 results · Rare Diseases  · Clear
🔒 Subscribers only
AUTH/2590/3/13
HCP Hospitality & Meetings Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Shire voluntary admission over Lancet reprint bar chart (Replagal)
Shire Pharmaceuticals voluntarily admitted that a The Lancet reprint (Mehta et al 2009), used to promote Replagal (agalsidase alfa), contained a bar chart that was incorrect and potentially mislead…
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2614/6/13
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Allergan market research
A health professional (and ex-Allergan employee) complained about an online “market research” survey his wife (a nurse) was invited to complete about injecting botulinum toxins.The survey refer…
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2673/11/13
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Recordati
An anonymous, contactable member of the public complained about alleged late/non-disclosure of clinical trial results, based on an ABPI-funded transparency study published in Current Medical Resear…
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2670/11/13
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Otsuka
An anonymous, contactable member of the public complained about alleged non-disclosure of clinical trial results for Samsca (tolvaptan), based on a transparency assessment published in Current Medi…
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2669/11/13
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Shire
An anonymous, contactable member of the public complained about alleged non-disclosure of clinical trial results for Resolor (prucalopride), based on an ABPI-funded transparency study published in …
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2665/11/13
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Genzyme (Sanofi)
An anonymous, contactable member of the public complained about clinical trial disclosure information referenced via an ABPI-funded study published in Current Medical Research & Opinion (11 Nov…
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2664/11/13
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Takeda
An anonymous, contactable member of the public complained about an ABPI-funded publication on clinical trial transparency (published in Current Medical Research & Opinion, 11 November 2013).The…
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2663/11/13
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Pierre Fabre
An anonymous, contactable member of the public complained about alleged non-disclosure of clinical trial results, based on a transparency assessment published in Current Medical Research & Opin…
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2657/11/13
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
AstraZeneca
An anonymous, contactable member of the public complained about alleged non-disclosure of clinical trial results, referencing a transparency study published in Current Medical Research & Opinio…
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2589/3/13
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Vifor Pharma UK
Pharmacosmos A/S complained about a Vifor Pharma UK advertisement for Ferinject (ferric carboxymaltose) (ref UK/FER/12/0163c) published in Gastrointestinal Nursing, January 2013.The ad showed a lea…
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2660/11/13
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
HRA Pharma
A member of the public made a complaint about clinical trial disclosure relating to ellaOne.The complaint was considered under the ABPI Code of Practice (Applicable Code year: 2012).The PMCPA concl…
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2514/6/12
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Baxter
Baxter reserved marketing space in Haemophilia for a FEIBA advertisement.The publisher requested draft artwork for typesetting; Baxter’s agency supplied draft copy, stating it was not to be print…
Clauses: NONE
2012 🔒 Subscribe
🔒 Subscribers only
AUTH/2499/4/12
Data & Publications Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Sanofi breached ABPI Code after sales rep told clinician an IFR for Mozobil “will” be approved
A pharmacist adviser for a specialised commissioning group complained about an email from a Sanofi haematology sales representative to a hospital clinician about local funding for Mozobil (plerixaf…
Clauses: 9.1,15.2
2012 🔒 Subscribe
🔒 Subscribers only
AUTH/2498/4/12
Data & Publications Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Merck Serono
Sandoz complained that Merck Serono provided a rucksack with a removable cool bag as a Saizen (somatropin) patient support item.Sandoz alleged the rucksack was not related to treatment of growth ho…
Clauses: 18.2
2012 🔒 Subscribe
🔒 Subscribers only
AUTH/2528/8/12
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Shire VPRIV press release
Genzyme complained about a Shire press release titled “Shire’s VPRIV (velaglucerase alfa for injection) Shows Significant Improvement in Gaucher-Related Bone Disease”, which included a promin…
Clauses: NONE
2012 🔒 Subscribe
🔒 Subscribers only
AUTH/2400/4/11
HCP Hospitality & Meetings Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Novo Nordisk v Baxter Healthcare
Novo Nordisk complained about Baxter’s promotion of FEIBA (Factor VIII Inhibitor Bypassing Activity).Two promotional items were challenged: a double-sided single page document, Introducing the FE…
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2385/2/11
Data & Publications Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Baxter Healthcare v Novo Nordisk
Baxter complained about a Novo Nordisk promotional leavepiece for NovoSeven (eptacog alfa (activated)) (ref UK/NV7/0809/0125a), specifically a page headed “How can NovoSeven help you cut costs?�…
Clauses: 4.1,4.3
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2409/6/11
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Anonymous v Cephalon (AUTH/2409/6/11)
An anonymous, non-contactable complainant (ex-employee) alleged a Cephalon medical affairs manager with signatory/approval powers was not a qualified doctor.The individual worked as an interim medi…
Clauses: NONE
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2436/9/11
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Shire
Genzyme complained about promotional claims on Shire’s UK website for VPRIV (velaglucerase alfa), an enzyme replacement therapy for Gaucher disease, comparing it with Genzyme’s Cerezyme (imiglu…
Clauses: NONE
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2451/11/11
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Sandoz Omnitrope patient support items
Merck Serono complained about three items supplied by Sandoz as part of an Omnitrope (somatropin) patient support package (“Sproutz”): a soft toy, a water bottle and a backpack/rucksack.The ite…
Clauses: NONE
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2442/10/11
Social Media & Digital Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Vifor
Pharmacosmos alleged Vifor Pharma UK breached an undertaking given in AUTH/2422/7/11 (dated 30 August 2011) by continuing to use a claim about Ferinject and hypersensitivity reactions.Two press rel…
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2422/7/11
Social Media & Digital Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Pharmacosmos v Vifor
Pharmacosmos complained about a six-page gatefolded Ferinject (ferric carboxymaltose) leavepiece (ref 0148/FER/2011) titled “Dosage and Administration Summary”, aimed at secondary care health p…
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2302/3/10
Data & Publications Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Ferring
A senior hospital pharmacist complained about a “Dear Pharmacist” letter (ref GL/317/02/10) from Ferring about Glypressin Solution for Injection (terlipressin acetate), mailed to NHS hospital p…
2010 🔒 Subscribe
🔒 Subscribers only
AUTH/2313/4/10
Data & Publications Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Teva v Chiesi
2010 🔒 Subscribe
← Prev 1 2 3 4 5 Next → Page 4 of 5 — 104 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews